In some patients with genetic forms of extreme insulin resistance, the cause of insulin resistance is a marked (290%) reduction in the number of insulin receptors on the cell surface. In the present work, we describe studies of insulin receptor biosynthesis in Epstein-Barr virus (EBV)-transformed lymphocytes from three patients (A-I, A-5, and A-8) with type A extreme insulin resistance.
Introduction
Cell surface receptors play a central role in mediating many important physiological processes, including hormone action and receptor-mediated endocytosis (1, 2) . Defects in these cell surface receptors contribute importantly to the pathogenesis of many human diseases (1) (2) (3) (4) (5) . In fact, in several rare genetic disease states, the primary defect appears to be a marked reduction in the number of receptors at the cell surface (3) (4) (5) (6) (7) . The genetic syndromes of extreme insulin resistance are among the best studied of these diseases (3, 4, (8) (9) (10) .
Recently, we have reported that cultured lymphocytes transformed with Epstein-Barr virus (EBV)' provide a powerful tool for investigating genetic diseases affecting the insulin receptor (4, 8, (10) (11) (12) (13) (14) (15) . In the present work, we have studied the biosynthesis of insulin receptors in cultured lymphocytes from four patients with the syndrome oftype A extreme insulin resistance. As compared with normal subjects, three of these patients have a marked reduction (.-90%) in the number of insulin receptors at the cell surface. In one patient (A-1), the reduction in receptor number results from a defect in receptor biosynthesis. In two other patients (A-5 and A-8), the receptor precursor is synthesized at a normal rate but there appears to be a block before the insertion ofthe mature receptor in the plasma membrane. In contrast, cells from the fourth patient (A-7) possess a normal number of insulin receptors. However, receptors from patient A-7 fail to couple insulin binding to insulin action, possibly as a result of a defect in the receptor-associated protein Icinase (16) . Interestingly, there appeared to be subtle defects in the posttranslational processing of insulin receptors from cells of patient A-7.
Methods
Patients. We have studied four patients with the syndrome of type A extreme insulin resistance (Table I ). All Cells. Lymphocytes were obtained from heparinized peripheral blood samples and transformed in vitro with EBV, according to previously established methods (8, 12) . Cells were grown in RPMI-1640 medium supplemented with 10% fetal calf serum (8) . '25I-Insulin binding studies were carried out as described elsewhere (8, 12) . '25IInsulin binding is presented as the ratio of bound to free '25I-insulin (B/F) at a cell density of IO' cells/ml and an 1251I-insulin concentration of 0.1 ng/ml.
Pulse-chase labeling studies (method I Pulse-chase labeling (method II). Cultured lymphocytes (-2 X 109 cells) were preincubated at 370C for 45 min in 100 ml of glucose-free RPMI-1640 supplemented with 10% dialyzed fetal calf serum. The cells were sedimented by centrifugation, resuspended in 100 ml of glucosefree medium containing [2-3H]mannose (0.25 mCi/ml), and divided equally between two tissue culture flasks (75 cm2 surface area). After the cells were incubated with [2-3H] mannose at 370C for 60 min, we added 1 ml of "stop" solution containing mannose (100 mM) and glucose (500 mM) dissolved in complete RPMI-1640 medium containing 10% fetal calf serum to each flask. Thereafter, the incubation was extended for an additional 1,5 or 4 h of "chase," At each time point, one flask of cells was utilized. The cells were washed three times with phosphate-buffered saline and the cell pellet was frozen at -20'C overnight. The following day, each cell pellet was solubilized in 2.5 ml of NaCI (150 mM)/Hepes (50 mM, pH 7.6)/Triton X-100 (2%, vol:vol) containing phenylmethylsulfonyl fluoride (2 mM) and aprotinin (I trypsin inhibitory unit/ml). The were always carried out in parallel on the same day using the same batch of cells. Determination ofincorporation ofradiolabeled precursors into TCAprecipitable material. In the pulse-chase labeling studies, we applied 0.02 ml of Triton extract of the cells (before ultracentrifugation) to a 15-cm2 piece of Whatman 1 filter paper (Whatman Laboratory Products, Inc., Clifton, NJ). The filter papers were washed for 3 d in 10% TCA with three changes of the wash, The filters were allowed to dry at room temperature, and then, they were placed into scintillation vials containing 0.6 ml of Protosol (New England Nuclear; Boston, MA) and 20 ml of Econofluor 2 (New England Nuclear). After incubating the vials overnight at 37°C, the radioactivity was determined with a scintillation counter. In general, the radioactivity incorporated into TCA-precipitable material was similar to that of cells from normal subjects and cells from insulinresistant patients studied the same day.
Cell surface iodination. The cell surface proteins of cultured lymphocytes were labeled by lactoperoxidase-catalyzed radioiodination, as described elsewhere (11, 15) . The receptors were solubilized and immunoprecipitated, as described for the pulse-chase studies (vide supra). Analytical SDS-PAGE. The receptors were solubilized in Triton X-100 and immunoprecipitated with antireceptor antiserum B-2, as described elsewhere (15, 21, 22) . The immunoprecipitates were analyzed using SDS-PAGE electrophoresis followed by fluorography, according to previously described methods (15, 21, 22) . The specific bands were excised from the gel ( Fig. 1 ) and the radioactivity was quantitated directly by liquid scintillation counting (21). In Fig. 6 , a scanning densitometer was employed to estimate the intensity of each band on the autoradiogram. It was shown that under these conditions, the amount of radioactivity in a band is proportional to the integrated area under the corresponding peak in the densitometric tracing.
NORMAL (P.L.)
TYPE A (A-1) Figure 1 . (8, 11, 15, 17) . The receptor defects first observed in fresh cells have been preserved in the cultured lymphocytes despite transformation of the cells with EBV and growth in vitro (8, 10) . In the present studies, we have investigated the biosynthesis of insulin receptors in three patients in whom extreme insulin resistance resulted from a marked reduction (_90%) in the number of insulin receptors at the cell surface (8, 15 Time course of receptor biosynthesis in cells from a normal subject and patient A-1. Specifically immunoprecipitated bands were excised from the slab gel described in Fig. 1 (18) . These two patients exhibit a reduction in the number of insulin receptors which is comparable with the decrease observed in patient A-I (Table I) . Nevertheless, a different biochemical mechanism appears to explain the defect observed in patients A-5 and A-8. Unlike our observations with cells from patient A-1 (Figs. 1-3) , the rate of biosynthesis of the receptor precursor does not differ from normal in patient A-8 (Fig. 4) . Similar results were obtained with cells from the sister, patient A-5 (data not shown). Therefore, it seems reasonable to conclude that there may be a block subsequent to the biosynthesis of the 1 90-kD precursor, but before the insertion of the mature receptor subunits (i.e., 135 and 95 kD) in the plasma membrane. In fact, there does appear to be a decrease in the radioactivity incorporated into the mature 135-and 95-kD receptor subunits in cells from patient A-8 (Fig. 4) . However, because of the diffuse nature of these bands in pulse- chase labeling studies, it is difficult to obtain precise quantitation of the magnitude of the decrease. Cells from an insulin-resistant patient (A-7) with a normal number of insulin receptors. While insulin receptors of patient A-7 have been reported to have an impaired tyrosine-specific protein kinase activity on the basis of studies with circulating monocytes ( 17) , this defect appears not to be expressed on the patient's EBV-transformed cultured lymphocytes (17, 20) . Nevertheless, we have employed our methods to investigate the structure and biosynthesis of insulin receptors in this patient's cultured lymphocytes (Fig. 6) (Fig. 5) . However, the patient's insulin receptors exhibited at least one abnormality in these biosynthetic studies. Although the mobility of the 190-kD receptor precursor does not appear to change during the chase period in cells from the norma Incorporation of [2-3Hjmannose into the insulin receptor and its precursor was assayed by excising the bands followed by scintillation counting, see Appendix 2. cells from patient A-7 appears to be processed to a form with an Mr of 10-20 kD higher than is observed in cells from the normal subject at 4 h in the chase period (Fig. 5) .
To pursue this question, we labeled the subunits ofthe insulin receptor by lactoperoxidase-catalyzed radioiodination (Fig. 6) . Using this technique, we did not detect any major abnormality in the Mr of the a-subunit (135 kD) or a-subunit (95 kD). However, cells from patient A-7 did appear to possess a markedly increased number of uncleaved 210-kD insulin receptor molecules (Fig. 6) . Although comparable quantities of 1251 were incorporated into the 135-kD subunit in cells from patient A-7 and the normal subject, almost 10-fold more radioactivity was incorporated into the 210-kD band in cells from patient A-7 (see Appendix 3).
Discussion
In three of the patients whom we have studied, extreme insulin resistance can be explained by a marked reduction in the number of insulin receptors at the cell surface. Previously, we have studied the rate of receptor degradation in cultured cells from these patients (15) . In those studies, the cell surface receptors were radioiodinated and the rate of receptor degradation was measured directly (15, 26, 27 posttranslational processing of the insulin receptor. Normally, the receptor precursor undergoes two processing steps to yield the mature receptor endopeptidase cleavage, and the maturation of the carbohydrate moiety (Figs. I and 2 ). The 2 10-kD glycoprotein which is immunoprecipitated by antireceptor antibodies represents the small fraction of receptor molecules that have escaped endopeptidase cleavage but nevertheless have undergone maturation of the carbohydrate moiety and insertion into the plasma membrane (21). This 210-kD species has previously been shown to function normally at least to the extent that it is capable ofbinding insulin and possesses insulin-stimulated protein kinase activity (28) . Interestingly, in cells from patient A-7, the amount ofthe uncleaved 2 10-kD form of the receptor is increased almost 10-fold (Fig. 6) . However, we do not yet understand either the explanation or the pathophysiological significance of this abnormality.
Diversity ofbiochemical defects. In previous studies, we and others have shown that there are multiple different types of receptor defects that may give rise to extreme insulin resistance (3, 4, 8-17, 29, 30) . Moreover, many patients with extreme insulin resistance do not possess any detectable defects in their insulin receptors (3, 4, 31, 32 
